• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 Vaccines in Patients With Cancer-A Welcome Addition, but There Is Need for Optimization.

作者信息

Korompoki Eleni, Gavriatopoulou Maria, Kontoyiannis Dimitrios P

机构信息

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

JAMA Oncol. 2021 Aug 1;7(8):1113-1114. doi: 10.1001/jamaoncol.2021.1218.

DOI:10.1001/jamaoncol.2021.1218
PMID:33983372
Abstract
摘要

相似文献

1
COVID-19 Vaccines in Patients With Cancer-A Welcome Addition, but There Is Need for Optimization.癌症患者的新冠疫苗——一项受欢迎的补充，但仍需优化。
JAMA Oncol. 2021 Aug 1;7(8):1113-1114. doi: 10.1001/jamaoncol.2021.1218.
2
Neutralizing SARS-CoV-2.中和 SARS-CoV-2
Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496.
3
Case Builds for Booster Shots for People with Cancer.为癌症患者接种加强针的案例。
Cancer Discov. 2022 Jan;12(1):7. doi: 10.1158/2159-8290.CD-NB2021-0398. Epub 2021 Nov 11.
4
Vaccines against COVID-19.针对新型冠状病毒肺炎的疫苗。
Anaesth Crit Care Pain Med. 2020 Dec;39(6):703-705. doi: 10.1016/j.accpm.2020.10.006. Epub 2020 Oct 20.
5
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.既往自然感染人群中新型冠状病毒2型（SARS-CoV-2）的抗体反应
N Engl J Med. 2021 Jul 1;385(1):90-92. doi: 10.1056/NEJMc2103825. Epub 2021 Apr 14.
6
COVID-19: Significance of antibodies.新型冠状病毒肺炎：抗体的意义
Hum Antibodies. 2020;28(4):287-297. doi: 10.3233/HAB-200429.
7
Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.研究表明新冠病毒感染后可产生持久免疫力，接种疫苗能大幅增强这种免疫力。
JAMA. 2021 Aug 3;326(5):376-377. doi: 10.1001/jama.2021.11717.
8
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.癌症患者对 COVID-19 疫苗的免疫反应：有希望的结果和谨慎的提示。
Cancer Cell. 2021 Aug 9;39(8):1045-1047. doi: 10.1016/j.ccell.2021.07.001. Epub 2021 Jul 3.
9
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.接种BNT162b2 mRNA疫苗后，医护人员和八旬老人针对新冠病毒的年龄和性别依赖性抗体反应。
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
10
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.单剂 mRNA 疫苗为 hACE2 转基因小鼠提供了针对 SARS-CoV-2 的长期保护。
Nat Commun. 2021 Feb 3;12(1):776. doi: 10.1038/s41467-021-21037-2.

引用本文的文献

1
COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults With Cancer.美国成年癌症患者中新冠病毒疾病2019（COVID-19）疫苗加强针的接种情况及有效性
JAMA Oncol. 2025 Jul 17. doi: 10.1001/jamaoncol.2025.2020.
2
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis.严重急性呼吸综合征冠状病毒2型疫苗接种与肿瘤发生的多打击假说
Cureus. 2023 Dec 17;15(12):e50703. doi: 10.7759/cureus.50703. eCollection 2023 Dec.
3
Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis.当前关于新冠病毒与癌症的全球研究态势：文献计量与可视化分析
World J Clin Oncol. 2022 Oct 24;13(10):835-847. doi: 10.5306/wjco.v13.i10.835.
4
COVID-19 Vaccination in Cancer Patients: A Review Article.新型冠状病毒肺炎（COVID-19）疫苗在癌症患者中的应用：一篇综述文章。
Cancer Control. 2022 Jan-Dec;29:10732748221106266. doi: 10.1177/10732748221106266.
5
From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics.从自愿接种疫苗政策到癌症患者强制接种 COVID-19 疫苗：生物伦理学中的实证和跨学科研究。
BMC Med Ethics. 2022 Aug 28;23(1):88. doi: 10.1186/s12910-022-00827-3.
6
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.针对癌症患者 COVID-19 突破性感染的疫苗有效性（英国癌症研究中心疫苗评估合作组织）：一项基于人群的病例对照研究。
Lancet Oncol. 2022 Jun;23(6):748-757. doi: 10.1016/S1470-2045(22)00202-9. Epub 2022 May 23.
7
COVID-19 vaccination and cancer immunotherapy: should they stick together?COVID-19 疫苗接种和癌症免疫疗法：它们应该结合在一起吗？
Br J Cancer. 2022 Jan;126(1):1-3. doi: 10.1038/s41416-021-01618-0. Epub 2021 Nov 19.
8
The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.接受检查点抑制剂治疗的癌症患者接种新冠病毒mRNA疫苗：我们已知与未知的情况
Immunotherapy. 2022 Feb;14(2):91-94. doi: 10.2217/imt-2021-0235. Epub 2021 Nov 8.
9
Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients.对肺癌或磨玻璃影患者中 COVID-19 疫苗犹豫的误解：324 例中国患者的横断面研究。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5016-5023. doi: 10.1080/21645515.2021.1992212. Epub 2021 Oct 29.
10
Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.106 例 WM 患者接种 SARS-CoV-2 疫苗后中和抗体反应不佳：一项前瞻性研究。
Blood Adv. 2021 Nov 9;5(21):4398-4405. doi: 10.1182/bloodadvances.2021005444.